424 related articles for article (PubMed ID: 28288987)
21. Elevated Endomyocardial Biopsy Macrophage-Related Markers in Intractable Myocardial Diseases.
Hayashi Y; Hanawa H; Jiao S; Hasegawa G; Ohno Y; Yoshida K; Suzuki T; Kashimura T; Obata H; Tanaka K; Watanabe T; Minamino T
Inflammation; 2015 Dec; 38(6):2288-99. PubMed ID: 26205770
[TBL] [Abstract][Full Text] [Related]
22. The results of transvenous endomyocardial biopsy can frequently be used to diagnose myocardial diseases in patients with idiopathic heart failure. Endomyocardial biopsies in 100 consecutive patients revealed a substantial incidence of myocarditis.
Parrillo JE; Aretz HT; Palacios I; Fallon JT; Block PC
Circulation; 1984 Jan; 69(1):93-101. PubMed ID: 6689651
[TBL] [Abstract][Full Text] [Related]
23. Endomyocardial expression of SDF-1 predicts mortality in patients with suspected myocarditis.
Zuern CS; Walker B; Sauter M; Schaub M; Chatterjee M; Mueller K; Rath D; Vogel S; Tegtmeyer R; Seizer P; Geisler T; Kandolf R; Lang F; Klingel K; Gawaz M; Borst O
Clin Res Cardiol; 2015 Dec; 104(12):1033-43. PubMed ID: 26008895
[TBL] [Abstract][Full Text] [Related]
24. Galectin-3 and fibulin-1 in systolic heart failure - relation to glucose metabolism and left ventricular contractile reserve.
Holmager P; Egstrup M; Gustafsson I; Schou M; Dahl JS; Rasmussen LM; Møller JE; Tuxen C; Faber J; Kistorp C
BMC Cardiovasc Disord; 2017 Jan; 17(1):22. PubMed ID: 28068900
[TBL] [Abstract][Full Text] [Related]
25. Soluble ST2 Receptor: Biomarker of Left Ventricular Impairment and Functional Status in Patients with Inflammatory Cardiomyopathy.
Obradovic DM; Büttner P; Rommel KP; Blazek S; Loncar G; von Haehling S; von Roeder M; Lücke C; Gutberlet M; Thiele H; Lurz P; Besler C
Cells; 2022 Jan; 11(3):. PubMed ID: 35159224
[TBL] [Abstract][Full Text] [Related]
26. Galectin-3 deficiency ameliorates fibrosis and remodeling in dilated cardiomyopathy mice with enhanced Mst1 signaling.
Nguyen MN; Ziemann M; Kiriazis H; Su Y; Thomas Z; Lu Q; Donner DG; Zhao WB; Rafehi H; Sadoshima J; McMullen JR; El-Osta A; Du XJ
Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H45-H60. PubMed ID: 30387702
[TBL] [Abstract][Full Text] [Related]
27. The biomarker plasma galectin-3 in advanced heart failure and survival with mechanical circulatory support devices.
Erkilet G; Özpeker C; Böthig D; Kramer F; Röfe D; Bohms B; Morshuis M; Gummert J; Milting H
J Heart Lung Transplant; 2013 Feb; 32(2):221-30. PubMed ID: 23352394
[TBL] [Abstract][Full Text] [Related]
28. Favorable Response to CD34+ Cell Therapy Is Associated with a Decrease of Galectin-3 Levels in Patients with Chronic Heart Failure.
Poglajen G; Ksela J; Frljak S; Zemljic G; Boznar Alic E; Cerar A; Vrtovec B
Dis Markers; 2019; 2019():8636930. PubMed ID: 31885743
[TBL] [Abstract][Full Text] [Related]
29. CT-1 (Cardiotrophin-1)-Gal-3 (Galectin-3) Axis in Cardiac Fibrosis and Inflammation.
Martínez-Martínez E; Brugnolaro C; Ibarrola J; Ravassa S; Buonafine M; López B; Fernández-Celis A; Querejeta R; Santamaria E; Fernández-Irigoyen J; Rábago G; Moreno MU; Jaisser F; Díez J; González A; López-Andrés N
Hypertension; 2019 Mar; 73(3):602-611. PubMed ID: 30612490
[TBL] [Abstract][Full Text] [Related]
30. Cardiac-deleterious role of galectin-3 in chronic angiotensin II-induced hypertension.
González GE; Rhaleb NE; D'Ambrosio MA; Nakagawa P; Liao TD; Peterson EL; Leung P; Dai X; Janic B; Liu YH; Yang XP; Carretero OA
Am J Physiol Heart Circ Physiol; 2016 Nov; 311(5):H1287-H1296. PubMed ID: 27496875
[TBL] [Abstract][Full Text] [Related]
31. Cardiac Inflammation Impedes Response to Cardiac Resynchronization Therapy in Patients With Idiopathic Dilated Cardiomyopathy.
Verdonschot JAJ; Merken JJ; van Stipdonk AMW; Pliger P; Derks KWJ; Wang P; Henkens MTHM; van Paassen P; Abdul Hamid MA; van Empel VPM; Knackstedt C; Luermans JGLM; Crijns HJGM; Brunner-La Rocca HP; Brunner HG; Poelzl G; Vernooy K; Heymans SRB; Hazebroek MR
Circ Arrhythm Electrophysiol; 2020 Nov; 13(11):e008727. PubMed ID: 32997547
[TBL] [Abstract][Full Text] [Related]
32. The predictive value of plasma biomarkers in discharged heart failure patients: role of galectin-3.
Leone M; Iacoviello M
Minerva Cardioangiol; 2016 Apr; 64(2):181-94. PubMed ID: 26426300
[TBL] [Abstract][Full Text] [Related]
33. Do clinical diagnoses correlate with pathological diagnoses in cardiac transplant patients? The importance of endomyocardial biopsy.
Luk A; Metawee M; Ahn E; Gustafsson F; Ross H; Butany J
Can J Cardiol; 2009 Feb; 25(2):e48-54. PubMed ID: 19214301
[TBL] [Abstract][Full Text] [Related]
34. Osteopontin and galectin-3 predict the risk of ventricular tachycardia and fibrillation in heart failure patients with implantable defibrillators.
Francia P; Adduci C; Semprini L; Borro M; Ricotta A; Sensini I; Santini D; Caprinozzi M; Balla C; Simmaco M; Volpe M
J Cardiovasc Electrophysiol; 2014 Jun; 25(6):609-16. PubMed ID: 24400815
[TBL] [Abstract][Full Text] [Related]
35. Galectin-3 in Patients with Acute Heart Failure: Preliminary Report on First Polish Experience.
Sygitowicz G; Tomaniak M; Filipiak KJ; Kołtowski Ł; Sitkiewicz D
Adv Clin Exp Med; 2016; 25(4):617-23. PubMed ID: 27629834
[TBL] [Abstract][Full Text] [Related]
36. Gal-3 (Galectin-3) and K
She G; Hou MC; Zhang Y; Zhang Y; Wang Y; Wang HF; Lai BC; Zhao WB; Du XJ; Deng XL
Hypertension; 2020 Feb; 75(2):393-404. PubMed ID: 31838908
[TBL] [Abstract][Full Text] [Related]
37. Association of Cardiac Galectin-3 Expression, Myocarditis, and Fibrosis in Chronic Chagas Disease Cardiomyopathy.
Souza BSF; Silva DN; Carvalho RH; Sampaio GLA; Paredes BD; Aragão França L; Azevedo CM; Vasconcelos JF; Meira CS; Neto PC; Macambira SG; da Silva KN; Allahdadi KJ; Tavora F; de Souza Neto JD; Dos Santos RR; Soares MBP
Am J Pathol; 2017 May; 187(5):1134-1146. PubMed ID: 28322201
[TBL] [Abstract][Full Text] [Related]
38. The usefulness of sST2 and galectin-3 as novel biomarkers for better risk stratification in hypertrophic cardiomyopathy.
Gawor M; Śpiewak M; Janas J; Kożuch K; Wróbel A; Mazurkiewicz Ł; Baranowski R; Marczak M; Grzybowski J
Kardiol Pol; 2017; 75(10):997-1004. PubMed ID: 28612913
[TBL] [Abstract][Full Text] [Related]
39. Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis.
Yu L; Ruifrok WP; Meissner M; Bos EM; van Goor H; Sanjabi B; van der Harst P; Pitt B; Goldstein IJ; Koerts JA; van Veldhuisen DJ; Bank RA; van Gilst WH; Silljé HH; de Boer RA
Circ Heart Fail; 2013 Jan; 6(1):107-17. PubMed ID: 23230309
[TBL] [Abstract][Full Text] [Related]
40. [Clinical, laboratory and instrumental criteria for myocarditis, established in comparison with myocardial biopsy: A non-invasive diagnostic algorithm].
Blagova OV; Osipova YV; Nedostup AV; Kogan EA; Sulimov VA
Ter Arkh; 2017; 89(9):30-40. PubMed ID: 29039828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
